Skip to main content
. 2022 Nov 29;10(2):608–617. doi: 10.1016/j.gendis.2022.10.023

Figure 2.

Fig. 2

Antibody responses to inactivated COVID-19 vaccines in obesity and overweight individuals. (A, B) The seropositivity rate and antibody titers of anti-RBD-IgG (A) and NAbs (B) in individuals with high BMI and normal BMI. (C, D) The seropositivity rate and antibody titers of anti-RBD-IgG (C) and NAbs (D) in individuals with obesity, overweight and normal BMI. The error bars in antibody titers indicate the 95%CI of the GMTs. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001. High BMI, BMI ≥ 24 kg/m2; normal BMI, BMI < 24 kg/m2. CI, confidential interval; anti-RBD-IgG, spike receptor-binding domain IgG antibody; GMTs, geometric mean titers; NAbs, neutralizing antibodies.